Institutional investors purchased a net $9.9 million shares of PRQR during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 31.99% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MIRAE ASSET GLOBAL INVESTMENTS C... Sold 103.00 shares of ProQR Therapeutics NV